CISATRACURIUM BESYLATE and DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS

Overview

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is the #11 most commonly reported adverse reaction for CISATRACURIUM BESYLATE, manufactured by Fresenius Kabi USA, LLC. There are 72 FDA adverse event reports linking CISATRACURIUM BESYLATE to DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS. This represents approximately 2.0% of all 3,661 adverse event reports for this drug.

Patients taking CISATRACURIUM BESYLATE who experience drug reaction with eosinophilia and systemic symptoms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is a less commonly reported adverse event for CISATRACURIUM BESYLATE, but still significant enough to appear in the safety profile.

Other Side Effects of CISATRACURIUM BESYLATE

In addition to drug reaction with eosinophilia and systemic symptoms, the following adverse reactions have been reported for CISATRACURIUM BESYLATE:

• OFF LABEL USE — 156 reports
• HYPOTENSION — 146 reports
• ANAPHYLACTIC SHOCK — 116 reports
• ANAESTHETIC COMPLICATION NEUROLOGICAL — 115 reports
• DRUG INEFFECTIVE — 113 reports
• DRUG INTERACTION — 113 reports
• ANAPHYLACTIC REACTION — 112 reports
• RHABDOMYOLYSIS — 83 reports
• CARDIAC ARREST — 82 reports
• ACUTE KIDNEY INJURY — 74 reports

Other Drugs Associated with DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS

The following drugs have also been linked to drug reaction with eosinophilia and systemic symptoms in FDA adverse event reports:

Does CISATRACURIUM BESYLATE cause DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS?

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS has been reported as an adverse event in 72 FDA reports for CISATRACURIUM BESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS with CISATRACURIUM BESYLATE?

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS accounts for approximately 2.0% of all adverse event reports for CISATRACURIUM BESYLATE, making it a notable side effect.

What should I do if I experience DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS while taking CISATRACURIUM BESYLATE?

If you experience drug reaction with eosinophilia and systemic symptoms while taking CISATRACURIUM BESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages